Search research articles
Contact Us
Filters
Showing results (71-80 of 128) with videos related to
Page
of 13
Sort By:
The Journal of Antimicrobial Chemotherapy
|
March 1, 1988
Kinetic properties of two plasmid-mediated beta-lactamases from Klebsiella pneumoniae with strong activity against third-generation cephalosporins
R Labia, A Morand, K Tiwari, et al.
Pathologie-Biologie
|
June 1, 1982
[Penetration of cloxacillin into human bone tissue after oral administration (author's transl)]
J Sirot, R Lopitaux, C Dumont, et al.
Infection
|
May 1, 1991
Treatment of a meningitis due to an Enterobacter aerogenes producing a derepressed cephalosporinase and a Klebsiella pneumoniae producing an extended-spectrum beta-lactamase
C de Champs, D Guelon, D Joyon, et al.
Antimicrobial Agents and Chemotherapy
|
October 30, 1999
Diversity of TEM mutants in Proteus mirabilis
R Bonnet, C De Champs, D Sirot, et al.
Presse Medicale (Paris, France : 1983)
|
May 15, 1993
[Haemophilus parainfluenzae meningitis in an 8-year-old boy]
M C Poupart, F Dabbaghi, C Chanal, et al.
Antimicrobial Agents and Chemotherapy
|
March 1, 1997
Novel extended-spectrum TEM-type beta-lactamase from an Escherichia coli isolate resistant to ceftazidime and susceptible to cephalothin
C Chanal-Claris, D Sirot, L Bret, et al.
Antimicrobial Agents and Chemotherapy
|
September 1, 1992
Nucleotide sequences of CAZ-2, CAZ-6, and CAZ-7 beta-lactamase genes
C Chanal, M C Poupart, D Sirot, et al.
Pathologie-Biologie
|
September 1, 1986
[Diffusion of ceftriaxone in human bone tissue]
B Soudry, J Sirot, R Lopitaux, et al.
Antimicrobial Agents and Chemotherapy
|
June 20, 2000
Prevalence of beta-lactamases among 1,072 clinical strains of Proteus mirabilis: a 2-year survey in a French hospital
C Chanal, R Bonnet, C De Champs, et al.
Journal of Clinical Microbiology
|
January 1, 1993
Clinical and bacteriological study of nosocomial infections due to Enterobacter aerogenes resistant to imipenem
C de Champs, C Henquell, D Guelon, et al.
Page
of 13
Search research articles
Search
Showing results (71-80 of 128) with videos related to
Sort By:
Page
of 13
The Journal of Antimicrobial Chemotherapy
|
March 1, 1988
Kinetic properties of two plasmid-mediated beta-lactamases from Klebsiella pneumoniae with strong activity against third-generation cephalosporins
R Labia, A Morand, K Tiwari, et al.
Pathologie-Biologie
|
June 1, 1982
[Penetration of cloxacillin into human bone tissue after oral administration (author's transl)]
J Sirot, R Lopitaux, C Dumont, et al.
Infection
|
May 1, 1991
Treatment of a meningitis due to an Enterobacter aerogenes producing a derepressed cephalosporinase and a Klebsiella pneumoniae producing an extended-spectrum beta-lactamase
C de Champs, D Guelon, D Joyon, et al.
Antimicrobial Agents and Chemotherapy
|
October 30, 1999
Diversity of TEM mutants in Proteus mirabilis
R Bonnet, C De Champs, D Sirot, et al.
Presse Medicale (Paris, France : 1983)
|
May 15, 1993
[Haemophilus parainfluenzae meningitis in an 8-year-old boy]
M C Poupart, F Dabbaghi, C Chanal, et al.
Antimicrobial Agents and Chemotherapy
|
March 1, 1997
Novel extended-spectrum TEM-type beta-lactamase from an Escherichia coli isolate resistant to ceftazidime and susceptible to cephalothin
C Chanal-Claris, D Sirot, L Bret, et al.
Antimicrobial Agents and Chemotherapy
|
September 1, 1992
Nucleotide sequences of CAZ-2, CAZ-6, and CAZ-7 beta-lactamase genes
C Chanal, M C Poupart, D Sirot, et al.
Pathologie-Biologie
|
September 1, 1986
[Diffusion of ceftriaxone in human bone tissue]
B Soudry, J Sirot, R Lopitaux, et al.
Antimicrobial Agents and Chemotherapy
|
June 20, 2000
Prevalence of beta-lactamases among 1,072 clinical strains of Proteus mirabilis: a 2-year survey in a French hospital
C Chanal, R Bonnet, C De Champs, et al.
Journal of Clinical Microbiology
|
January 1, 1993
Clinical and bacteriological study of nosocomial infections due to Enterobacter aerogenes resistant to imipenem
C de Champs, C Henquell, D Guelon, et al.
Page
of 13